Issue navigation
Volume 30, Issue 4, April 2025
Epidemiology characteristics and clinical outcomes of composite Hodgkin lymphoma and diffuse large B-cell lymphoma using machine learning
The Oncologist, Volume 30, Issue 4, April 2025, oyae221, https://doi.org/10.1093/oncolo/oyae221
This article provides the first comprehensive report of composite Hodgkin lymphoma and diffuse large B-cell lymphoma.
Editorial
Early phase trials: the perils of nonpublication
The Oncologist, Volume 30, Issue 4, April 2025, oyaf041, https://doi.org/10.1093/oncolo/oyaf041
Breast Cancer
Original Articles
Retrospective analysis to validate the CTS5 in patients from El Álamo IV registry and GEICAM adjuvant studies
The Oncologist, Volume 30, Issue 4, April 2025, oyaf040, https://doi.org/10.1093/oncolo/oyaf040
Treatment patterns and associated outcomes among patients with HER2+ metastatic breast cancer in the United States: an observational cohort study
The Oncologist, Volume 30, Issue 4, April 2025, oyae280, https://doi.org/10.1093/oncolo/oyae280
With the expanding treatment options for HER2+ metastatic breast cancer, updated assessments of contemporary treatment patterns and clinical outcomes are needed. This study conducted such an assessment using data from real-world oncology practices.
Tumor-infiltrating lymphocytes as predictive biomarkers in neoadjuvant treatment of HER2-positive breast cancer
The Oncologist, Volume 30, Issue 4, April 2025, oyaf054, https://doi.org/10.1093/oncolo/oyaf054
Clinical Trial Results
Original Article
A phase II trial of sitravatinib + nivolumab after progression on immune checkpoint inhibitor in patients with metastatic clear cell RCC
The Oncologist, Volume 30, Issue 4, April 2025, oyaf053, https://doi.org/10.1093/oncolo/oyaf053
Gastrointestinal Cancer
Original Article
Pancreatic enzyme replacement therapy in advanced adenocarcinoma of the pancreas improved overall survival: a retrospective, single institution study
The Oncologist, Volume 30, Issue 4, April 2025, oyaf014, https://doi.org/10.1093/oncolo/oyaf014
Genitourinary Cancer
Original Articles
Clinical and pathological outcomes of deferred nephrectomy in patients with metastatic and locally advanced RCC after immune checkpoint inhibitors
The Oncologist, Volume 30, Issue 4, April 2025, oyaf004, https://doi.org/10.1093/oncolo/oyaf004
Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomes
The Oncologist, Volume 30, Issue 4, April 2025, oyaf049, https://doi.org/10.1093/oncolo/oyaf049
Global Health and Cancer
Review Article
A scoping review of clinical communication in cancer care in Africa
The Oncologist, Volume 30, Issue 4, April 2025, oyaf039, https://doi.org/10.1093/oncolo/oyaf039
Original Article
Treatment delays in patients with lung cancer: a retrospective study conducted at the National Cancer Institute of Mexico between 2004 and 2021
The Oncologist, Volume 30, Issue 4, April 2025, oyae358, https://doi.org/10.1093/oncolo/oyae358
Head and Neck Cancers
Original Article
Outcomes for recurrent or metastatic head and neck cancer by HPV status: a systematic review and meta-analysis
The Oncologist, Volume 30, Issue 4, April 2025, oyaf043, https://doi.org/10.1093/oncolo/oyaf043
Health Outcomes and Economics of Cancer Care
Review Article
Medical accuracy of artificial intelligence chatbots in oncology: a scoping review
The Oncologist, Volume 30, Issue 4, April 2025, oyaf038, https://doi.org/10.1093/oncolo/oyaf038
Immuno-Oncology
Original Article
Identifying predictors of overall survival among patients with TMB-low metastatic cancer treated with immune checkpoint inhibitors
The Oncologist, Volume 30, Issue 4, April 2025, oyaf078, https://doi.org/10.1093/oncolo/oyaf078
Medical Ethics
Commentary
Primum succurrere; first hasten to help
The Oncologist, Volume 30, Issue 4, April 2025, oyae368, https://doi.org/10.1093/oncolo/oyae368
Original Article
Barriers to publishing early phase clinical trials: the oncologists’ perspective
The Oncologist, Volume 30, Issue 4, April 2025, oyaf042, https://doi.org/10.1093/oncolo/oyaf042
New Drug Development and Clinical Pharmacology
Original Article
Phase I study of oral metronomic gemcitabine (D07001) in patients with advanced solid tumors
The Oncologist, Volume 30, Issue 4, April 2025, oyaf051, https://doi.org/10.1093/oncolo/oyaf051
